Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.990
+0.320 (6.85%)
At close: Mar 6, 2026, 4:00 PM EST
5.12
+0.13 (2.61%)
After-hours: Mar 6, 2026, 7:11 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $52.22 million as of March 6, 2026. Its market cap has increased by 45.84% in one year.
Market Cap
52.22M
Enterprise Value
26.71M
1-Year Change
45.84%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $52.22M, a decrease of -28.31%. That is a compound annual growth rate of -7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 52.22M | -11.64% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 55.57M |
| OS Therapies | 55.29M |
| Edesa Biotech | 54.43M |
| NRx Pharmaceuticals | 54.18M |
| Alterity Therapeutics | 53.42M |
| Nutriband | 53.00M |
| MindWalk Holdings | 51.83M |
| Plus Therapeutics | 51.07M |